Lyra Therapeutics (LYRA) Assets (2019 - 2025)

Quarterly Assets fell 45.58% to $36.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $36.1 million through Dec 2025, down 45.58% year-over-year, with the annual reading at $36.1 million for FY2025, 45.58% down from the prior year.

Lyra Therapeutics' Assets history spans 7 years, with the latest figure at $36.1 million for Q4 2025.

  • Assets came in at $36.1 million for Q4 2025, down from $43.7 million in the prior quarter.
  • In the past five years, Assets ranged from a high of $142.6 million in Q4 2023 to a low of $36.1 million in Q4 2025.
  • The 5-year median for Assets is $77.5 million (2021), against an average of $86.6 million.
  • Year-over-year, Assets skyrocketed 100.43% in 2022 and then plummeted 60.21% in 2025.
  • Lyra Therapeutics' Assets stood at $54.9 million in 2021, then surged by 100.43% to $110.0 million in 2022, then rose by 29.67% to $142.6 million in 2023, then tumbled by 53.47% to $66.3 million in 2024, then plummeted by 45.58% to $36.1 million in 2025.
  • Per Business Quant, the three most recent readings for LYRA's Assets are $36.1 million (Q4 2025), $43.7 million (Q3 2025), and $52.6 million (Q2 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn - 14.93 Mn
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn - 37.37 Mn
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn 1.73 Bn
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - 78.88 Mn
5 Akari Therapeutics 605.66 Bn 605.66 Bn - 33.89 Mn
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn 26.48 Bn
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn 40.87 Bn
8 Evaxion A 65.12 Bn 65.10 Bn - 23.64 Mn
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn 5.13 Bn
10 Lyra Therapeutics - - - 36.11 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 36.11 Mn
Sep 30, 2025 43.71 Mn
Jun 30, 2025 52.57 Mn
Mar 31, 2025 56.32 Mn
Dec 31, 2024 66.35 Mn
Sep 30, 2024 78.76 Mn
Jun 30, 2024 94.58 Mn
Mar 31, 2024 141.53 Mn
Dec 31, 2023 142.60 Mn
Sep 30, 2023 120.58 Mn
Jun 30, 2023 125.68 Mn
Mar 31, 2023 93.87 Mn
Dec 31, 2022 109.97 Mn
Sep 30, 2022 119.46 Mn
Jun 30, 2022 130.04 Mn
Mar 31, 2022 47.35 Mn
Dec 31, 2021 54.87 Mn
Sep 30, 2021 67.76 Mn
Jun 30, 2021 76.33 Mn
Mar 31, 2021 72.92 Mn
Dec 31, 2020 80.83 Mn
Sep 30, 2020 87.33 Mn
Jun 30, 2020 92.72 Mn
Mar 31, 2020 40.77 Mn
Dec 31, 2019 14.96 Mn